Asia-Pacific Region Begins Adopting Lifecycle Approaches To Process Validation
Executive Summary
Pharmaceutical manufacturers in India should be aware that inspectors may be looking to see that lifecycle approaches to process validation have been used in their systems with the country’s adoption of a WHO guideline on process validation. ASEAN is also about to issue guidance that tells manufacturers how to design a lifecycle approach to validating vaccine manufacturing processes.
You may also be interested in...
Uptake on Annex 15 Slow in the Asia-Pacific Region
Widespread adoption of PIC/S GMP guidelines in the Asia-Pacific region has not necessarily translated into uptake of Annex 15 and the lifecycle approach to process validation that has taken hold in the US and the EU, a consultant tells ISPE meeting.
ASEAN Countries Make Progress in Harmonizing Pharmaceutical Quality Guidelines
Southeast Asian authorities are making progress in aligning pharmaceutical approval and quality regulations with ICH, but country-specific requirements are still an impediment.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”